Onderneming BioGend Therapeutics Co., Ltd.
Aandelen
6733
TW0006733009
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
36,8 TWD | -2,65% | +0,27% | -3,79% |
Vakgebied
Verkoop per activiteit
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Orthopedic Medical Devices
100,0
%
| 31 | 100,0 % | 110 | 100,0 % | +249,51% |
Verkoop per regio
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Taiwan
66,9
%
| 31 | 99,0 % | 74 | 66,9 % | +136,18% |
Japan
22,6
%
| 0 | 0,0 % | 25 | 22,6 % | +248.700,00% |
Others
10,5
%
| 0 | 1,0 % | 11 | 10,5 % | +3.730,67% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Te Li Chen
CEO | Chief Executive Officer | 55 | 07-07-16 |
Tsang Cheng Lin
CEO | Chief Executive Officer | - | 30-04-18 |
Shu Wei Chao
DFI | Director of Finance/CFO | - | - |
Liang Yan Wang
IRC | Investor Relations Contact | - | 01-09-17 |
Po Chih Chang
PRN | Corporate Officer/Principal | - | 01-08-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jung Chin Lin
BRD | Director/Board Member | 70 | 20-05-19 |
Hai Yi Ma
BRD | Director/Board Member | - | 20-05-18 |
Te Li Chen
CEO | Chief Executive Officer | 55 | 07-07-16 |
Shao Feng Chien
BRD | Director/Board Member | - | 20-05-18 |
Tsang Cheng Lin
CEO | Chief Executive Officer | - | 30-04-18 |
Hsuan hao Chang
BRD | Director/Board Member | - | 20-05-18 |
En Tzu Liu
BRD | Director/Board Member | - | 20-05-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 123 076 000 | 72 655 026 ( 59,03 %) | 0 | 59,03 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,79% | 140 mln. | |
+49,41% | 56,95 mld. | |
+40,20% | 40,26 mld. | |
-6,72% | 39,32 mld. | |
-5,96% | 28,37 mld. | |
+12,99% | 26,45 mld. | |
-19,82% | 19,41 mld. | |
+32,35% | 12,54 mld. | |
-0,08% | 12,15 mld. | |
+25,18% | 12,21 mld. |
- Beurs
- Aandelen
- Koers 6733
- Onderneming BioGend Therapeutics Co., Ltd.